English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 感染症 > 欧州におけるHIV/AIDS治療市場
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州におけるHIV/AIDS治療市場

European HIV/AIDS Therapeutics Markets

発行 Frost & Sullivan
出版日 2009年04月 商品コード 86103
ページ情報 英文 59 Pages
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the current and future trends in the European market.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary for the European HIV/AIDS Therapeutics Market

  • Summary

2. GLOSSARY

Glossary of Terms

  • Key Words and Acronyms

3. RESEARCH METHODOLOGY

Research Methodology for the European HIV/AIDS Therapeutics Market

  • Research Methodology and Segmentation

4. INDUSTRY CHALLENGES

Challenges Facing the European HIV/AIDS Industry

  • Challenges

5. EUROPEAN HIV/AIDS THERAPEUTICS MARKET OUTLOOK

Introduction

  • Disease Description
  • Treatment Options
  • Epidemiology

Country Overview

  • France
  • Germany
  • Italy
  • Spain
  • The United Kingdom

6. MARKET ENGINEERING RESEARCH FOR THE EUROPEAN HIV/AIDS THERAPEUTICS MARKET

European HIV/AIDS Therapeutics Market

  • Introduction
  • Market Engineering Measurements
  • Market Drivers
  • Market Restraints
  • Revenue Forecasts

7. COMPETITOR ANALYSIS

Competitor Profiles

  • Competitive Analysis
  • Profiles

8. STRATEGIC RECOMMENDATIONS

Strategic Recommendations for the Market Participants

  • Recommendations

9. DECISION SUPPORT DATABASES

Decision Support Databases

  • Total Healthcare Expenditure
  • Pharmaceutical R&D Expenditure
  • Total Population
  • Birth Rates
  • Mortality Rates
Back to Top